Main Page
Faculty Deanship
Dean
Health Empowerment Unit
Strategic Planning Unit
Development and Quality Unit
Medical and Bioethics Unit
Vice Dean for Graduate Studies and Research
Vice Dean for Female Section
Vice dean for Academic Affairs
Examination and Assessment Unit
Internship and Alumni Unit
Student Research Unit
E-learning Unit
Student Mentoring and Support Unit
Community Service Unit
Talent and Creativity Care Unit
Continuing Education Unit
Neuroscience Research Unit
Vice Deanship of Clinical Affairs / Administration
Organizational Structure
Departments
Basic Sciences
Department of Anatomy
Department of Pharmacology
Department of Pathology
Department of Microbiology and Medical Parasitolog
Deparment of Clinical Biochemistry
Department of Physiology
Department of Medical Genetics
Clinical Sciences
Department of Otorhinolaryngology
Department of Obstetrics and Gynecology
Department of Hematology
Department of Medical Education
Department of Anesthesia
Department of Family Medicine
Department of Community Medicine
Department of Surgery
Department of Orthopedic Surgery
Department of ophthalmology
Department of Radiology
Department of Internal Medicine
Department of Pediatrics
Department of Emergency Medicine
Department of Urology
Department of Dermatology
Latest News
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Faculty of Medicine
Document Details
Document Type
:
Article In Journal
Document Title
:
QUALITY OF LIFE AFTER INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL CARCINOMATOSIS
QUALITY OF LIFE AFTER INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL CARCINOMATOSIS
Document Language
:
English
Abstract
:
Objective: To assess the functional status and quality of life ( QOL ) of 12 patients with disseminated peritoneal cancer before and after intraperitoneal chemotherapy (IPCT). Design: Patients with confirmed diagnosis of malignant ascites originating from gastrointestinal tract, gynecologic or other malignancies with peritoneal implants were enrolled in this study. Twelve patients completed the Functional Assessment of Cancer therapy scale to assess quality of life and the Visual Analogue scale to assess common symptoms before and after palliative abdominal paracentesis with intraperitoneal chemotherapy (IPCT). Results: Twelve patients enrolled, 8 gastrointestinal, 3 gynecologic malignancies and 1 with pseudomyxoma peritonie. All with terminal advanced stage malignancy. Mean number of days required for palliative abdominal paracentesis before (IPCT) was 6.7 days (3-20 days) while mean number of days after IPCT was 18.9 days (10-35 days). Eleven out of 12 patients had relief of their symptoms and improvement in QOL. Side effects were minimal and tolerable. Conclusion: Intraperitoneal chemotherapy improves QOL and increase the duration required for palliative abdominal paracentesis for terminal cancer patients with malignant ascites with minimal toxicity
ISSN
:
1682-024X
Journal Name
:
Pakistan Journal of Medical Sciences
Volume
:
21
Issue Number
:
1
Publishing Year
:
1425 AH
2005 AD
Article Type
:
Article
Added Date
:
Monday, February 7, 2011
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
محمود الاحول
Al-Ahwal, Mahmoud
Researcher
Doctorate
Files
File Name
Type
Description
28923.pdf
pdf
Back To Researches Page